High frequency of the combined presence of QRDR mutations and PMQR determinants in multidrug-resistant Klebsiella pneumoniae and Escherichia coli isolates from nosocomial and community-acquired infections

References

1. Seyedpour SM, Eftekhar F. Quinolone susceptibility and detection of qnr and aac(6')-Ib-cr genes in community isolates of Klebsiella pneumoniae. Jundishapur J Microbiol 2014; 7:e11136 [View Article][PubMed]
   [Google Scholar]
2. Piekarska K, Wołkowicz T, Zacharczuk K, Rzeczkowska M, Chróst A et al. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland. Int J Antimicrob Agents 2015; 45:238–243 [View Article][PubMed]
   [Google Scholar]
3. Tanwar J, das S, Fatima Z, Hameed S. Multidrug resistance: an emerging crisis. Interdiscip Perspect Infect Dis 2014; 2014:1–7 [View Article]
   [Google Scholar]
4. Ruppé Étienne, Woerther P-L, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care 2015; 5:21 [CrossRef]
   [Google Scholar]
5. Dalhoff A. Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis 2012; 2012:1–37 [View Article][PubMed]
   [Google Scholar]
6. Rodríguez-Martínez JM, Cano ME, Velasco C, Martínez-Martínez L, Pascual A et al. Plasmid-mediated quinolone resistance: an update. J Infect Chemother 2011; 17:149–182 [View Article][PubMed]
   [Google Scholar]
7. Martínez-Martínez L, Eliecer Cano M, Manuel Rodríguez-Martínez J, Calvo J, Pascual A. Plasmid-mediated quinolone resistance. Expert Rev Anti Infect Ther 2008; 6:685–711 [View Article][PubMed]
   [Google Scholar]
8. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006; 42:S82–S89 [View Article][PubMed]
   [Google Scholar]
9. Davey PG, Marwick C. Appropriate vs. inappropriate antimicrobial therapy. Clin Microbiol Infect 2008; 14:15–21 [View Article][PubMed]
   [Google Scholar]
10. Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care 2014; 18:596 [View Article][PubMed]
    [Google Scholar]
11. Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res 2010; 10:441–451 [View Article][PubMed]
    [Google Scholar]
12. Bouchillon S, Hoban DJ, Badal R, Hawser S. Fluoroquinolone resistance among gram-negative urinary tract pathogens: global smart program results, 2009-2010. Open Microbiol J 2012; 6:74–78 [View Article][PubMed]
    [Google Scholar]
13. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article][PubMed]
    [Google Scholar]
14. Gulen TA, Guner R, Celikbilek N, Keske S, Tasyaran M. Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant Acinetobacter baumannii. Int J Infect Dis 2015; 38:32–35 [View Article][PubMed]
    [Google Scholar]
15. Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA. The Sanford Guide to Antimicrobial Therapy Sperryville, VA, Antimicrobial Therapy 2007 p. 37
    [Google Scholar]
16. Lodise TP, Patel N, Kwa A, Graves J, Furuno JP et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 2007; 51:3510–3515 [View Article][PubMed]
    [Google Scholar]
17. Schwarz S, Silley P, Simjee S, Woodford N, van Duijkeren E et al. Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals. J Antimicrob Chemother 2010; 65:601–604 [View Article][PubMed]
    [Google Scholar]
18. Capuano VSC. Estudo comparativo de métodos fenotípicos e biomoleculares para determinação de resistência an antibióticos em cepas de Salmonella spp isoladas de coiro e carcaça de bovinos e produtos cárneos. Masters Dissertation. Universidade De São Paulo, Faculdade De Ciências Farmacêuticas. São Paulo 2012
    [Google Scholar]
19. CLSI Performance Standards for Antimicrobial Susceptibility Testing; Document M100-S24 Wayne, PA: Clinical and Laboratory Standards Institute; 2014
    [Google Scholar]
20. Galetti R. Estudo de Pseudomonas Aeruginosa Produtoras de Metalo-Beta-Lactamases e de Genes Envolvidos Na Resistência Aos Carbapenêmicos. 49 F Master Thesis - Faculdade De Ciências Farmacêuticas, Universidade De São Paulo, Ribeirão Preto, Brazil 2010
    [Google Scholar]
21. Sengupta S, Chattopadhyay MK, Grossart HP. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol 2013; 4:47 [View Article][PubMed]
    [Google Scholar]
22. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacol Ther 2015; 40:277–283[PubMed]
    [Google Scholar]
23. Chakrabarty RP, Sultana M, Shehreen S, Akter S, Hossain MA. Contribution of target alteration, protection and efflux pump in achieving high ciprofloxacin resistance in Enterobacteriaceae. AMB Express 2016; 6:126 [View Article][PubMed]
    [Google Scholar]
24. Rodríguez-Martínez JM, Machuca J, Cano ME, Calvo J, Martínez-Martínez L et al. Plasmid-mediated quinolone resistance: two decades on. Drug Resist Updat 2016; 29:13–29 [View Article][PubMed]
    [Google Scholar]
25. Yang HY, Nam YS, Lee HJ. Prevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in Korea. Can J Infect Dis Med Microbiol 2014; 25:163–169[PubMed]
    [Google Scholar]
26. Bado I, Gutiérrez C, García-Fulgueiras V, Cordeiro NF, Araújo Pirez L et al. CTX-M-15 in combination with aac(6')-Ib-cr is the most prevalent mechanism of resistance both in Escherichia coli and Klebsiella pneumoniae, including K. pneumoniae ST258, in an ICU in Uruguay. J Glob Antimicrob Resist 2016; 6:5–9 [View Article][PubMed]
    [Google Scholar]
27. Moreira APA. Infecções hospitalares por Enterobacteriaceae produtora de β-lactamase de amplo espectro (ESBL): ocorrência e preditores de mortalidade em um hospital universitário mineiro. Masters Dissertation, Universidade Federal De Uberlândia, Instituto De Ciências Biomédicas, Uberlândia 2011
28. Minarini LA, Darini AL. Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil. Braz J Microbiol 2012; 43:1309–1314 [View Article][PubMed]
    [Google Scholar]
29. Norouzi A, Azizi O, Hosseini H, Skakibaie S, Shakibaie M. Amino acid substitution mutations analysis of gyrA and parC genes in clonal lineage of Klebsiella pneumoniae conferring high-level quinolone resistance. Res Infect Dis Trop Med 2014; 2:109–117
    [Google Scholar]
30. Asadpour L. Study of amino acid alteration in graA & parC genes in quinolone resistant Klebsiella pneumoniae. Crescent J Med Biol Sci 2017; 4:3–6
    [Google Scholar]
31. Martínez-Martínez L, Pascual A, García I, Tran J, Jacoby GA. Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother 2003; 51:1037–1039 [View Article][PubMed]
    [Google Scholar]
32. Jeong JY, Kim ES, Choi SH, Kwon HH, Lee SR et al. Effects of a plasmid-encoded qnrA1 determinant in Escherichia coli strains carrying chromosomal mutations in the acrAB efflux pump genes. Diagn Microbiol Infect Dis 2008; 60:105–107 [View Article][PubMed]
    [Google Scholar]
33. Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr 2014; 2: doi:10.1128/microbiolspec.PLAS-0006-2013 [View Article][PubMed]
    [Google Scholar]